Leading pharmaceutical companies, emerging biotech firms, and academic institutions
trust Article Galaxy to automate literature acquisition—resulting in faster workflows, lower costs,
and better outcomes. Read their stories.
Seventy percent of the world's top pharmaceutical companies rely on Article Galaxy to simplify and enhance their literature acquistion strategies for research and development, pharmacovigilance and drug safety, medical affairs, and regulatory submissions.
Small and medium-sized biotech companies use Article Galaxy to optimize the value of their resources and reduce R&D costs—whether for drug discovery, medical affairs, or regulatory approval.
Companies across the medical devices space leverage Article Galaxy to automate and improve the way they find, access, and manage scholarly research for systematic literature reviews and clinical evaluation reports.